tion.1-14 Many patients undergo multiple tests for the evaluation of suspected CAD. In such patients, whereas the additive diagnostic value of sequential testing has been elucidated, 15 201T1 imaging, and coronary angiographic data from both the Massachusetts General Hospital (MGH) and the University of Virginia (UVA) patients have been described in detail in previous reports.36 A limited summary of patient characteristics and methods is provided here. Data from both patient cohorts were used to develop models for predicting prognosis. To determine goodness-of-fit, these models were evaluated in the same patients from whom they were developed. To determine clinical use, these models were tested in the unrelated patient sample from the other institution undergoing similar testing.
Patient Populations
Both groups of subjects (325 from MGH and 383 from UVA) were referred for evaluation of chest pain and underwent both exercise 20 In this instance, we were interested in predicting survival based on only the risk factors from the unrelated sample. We were not interested in predictions that became confounded with differences in underlying survival rates between the two cohorts. As a result, predictions in one sample are based on the underlying survival curve for that sample, whereas for the unrelated sample, coefficients from important risk factor relations observed in that sample were used. Any departures from the Kaplan-Meier estimates in one group were attributed to poor prediction from risk factors found to be important elsewhere (see "Appendix" for further details).
The predicted rates were calculated by averaging the individual survival probabilities for each patient within each year. The predicted and observed survival rates were then compared using a Kolmogorov-Smirnov twosample test. 39 This analysis was performed both for the patient cohorts as a whole as well as for low-risk and high-risk subgroups within the cohorts. Results 
Individual Value of Risk Factors for Determining Prognosis
Event rates for both patient samples are depicted in Table 1 . Of the four clinical variables analyzed, history of myocardial infarction was the only significant predictor of cardiac events in the MGH cohort ( Table 2) . Patients with prior infarction suffered an event at more than twice the rate of those without such a history after adjusting for age, /3-blocker therapy, and type of chest pain (Table 3 ). In comparison, the use of /3-blockers was the only significant predictor of cardiac events in patients from UVA (Table 2 ). In this cohort, patients treated with /3-blockers had a near doubling of risk compared to those not on these medications after adjusting for age, history of infarction, and type of chest pain (Table 3) .
A suboptimal heart rate response during the exercise stress test portended a worse prognosis in both patient samples (Table 2) . A patient whose heart rate rose 20 beats per minute less than an otherwise similar patient had a 30% excess risk of an event at MGH and a nearly twofold excess at UVA. The inability to exercise for a longer duration was a significant predictor of events in the UVA sample on univariate analysis but not on multivariate analysis ( Table 2 ). The occurrence of ST segment depression or abnormal systolic blood pressure response (fall or failure to rise during exercise) were not predictors of events in either patient cohort.
All 20`T1 variables (lung/heart 20`TI ratio and the number of persistent and redistributing defects) were significant univariate predictors of events in the MGH sample ( Table 2 ). The lung/heart 20`TI ratio superceded the other variables on multivariate analysis (Table 3) . A difference in this ratio of 0.15 translated into a greater-than-twofold increase in the risk of events. When this ratio was excluded from analysis, the number of segments demonstrating redistribution was the most powerful 20`TI predictor of events. A two-segment difference in the number of segments with redistribution increased the event rate twofold (Table 3) . Although the number of persistent defects was a significant univariate predictor of events (Table 2) , it did not predict events on multivariate analysis.
In the UVA cohort, in which lung/heart 201T1 ratio had not been quantitated, the number of segments with redistribution was the best 201T1 predictor of cardiac-related events. A two-segment difference in the number of redistributing segments increased the risk of an event greater than twofold (Table 3) . Unlike the results from MGH, the number of persistent defects was not a significant predictor of events in this patient cohort on univariate analysis. The number of diseased coronary arteries was a significant predictor of events at both medical centers. A twofold increase in the event rate for each additional diseased artery was noted in both samples (Table 3) . Of Model was derived from the same population.
cant additional information ( Figure 1B) . The inclusion of the number of segments showing redistribution on 201T1 imaging improved the prognostic information at both institutions beyond that provided by clinical and exercise stress test data alone ( Figures  1A and 1B) . When the lung/heart 201T1 ratio was used in lieu of the number of segments with redistribution in the MGH sample, the improvement in the prognostic information was even greater than that afforded by the inclusion of the number of segments with redistribution ( Figure 1A) .
The information from coronary angiography did not add to the combined information obtained from the clinical, exercise stress test, and 201T1 data in the MGH cohort when the lung/heart 201T1 ratio was included in the analysis ( Figure 1A) . Moreover, the combination of clinical, exercise stress test, and coronary angiographic data was not as prognostically powerful as the combination of clinical, exercise stress test, and lung/heart 201T1 ratio ( Figure 1A ). When the lung/heart ratio was excluded from analysis and the number of segments with redistribution was used instead, however, coronary angiography provided some additional prognostic information to that available from the clinical, exercise stress test, and 201T1 data in this patient cohort ( Figure 1A) .
Similarly, in the UVA sample, where lung/heart 20`TI ratio had not been assessed and the number of segments with redistribution was used as the 201T1 imaging variable, coronary angiography was of significant additional prognostic value to that obtained from the combination of clinical, exercise stress test, and 201T1 data ( Figure 1B ). When 201T1 data were excluded altogether from analysis, coronary angiography added significantly to clinical and exercise stress test data at both centers ( Figures 1A and 1B (Figure 2 ). Two subgroups were defined to further examine the performance of this model: a high-risk subgroup of 46 patients who had a history of a myocardial infarction and a lung/heart 201T1 ratio of >0.51, which is >2SD above the mean normal value,29 and a low-risk subgroup of 73 patients without a history of myocardial infarction and a lung/heart 201T1 ratio of <0.51. In these two situations, as in the entire patient cohort, there were no significant differences between the observed and predicted event rates (Figure 2 ). Because the lung/heart 201T1 ratio had not been derived in this sample, model A could not be validated in the UVA cohort. A model using the number of segments demonstrating redistribution (model B) was applied to this group instead. Before testing the validity of the model, however, it was assessed in the MGH sample from which it was derived. The overall observed and predicted event rates were very close for the entire cohort ( Figure 3A ). Low-risk (67 patients without a history of infarction and no segments demonstrating redistribution) and high-risk (33 patients with a history of infarction and more than one segment showing redistribution) subgroups were also identified in this patient sample. Similar to the entire cohort, the model provided reasonable predictions of events in these subgroups ( Figure 3A ). When this model was used in the 299 patients from UVA, it appeared to perform poorly, although there was no significant difference between the overall observed and predicted event rates ( Figure 3B) . Here, the MGH model overpredicted actual survival in the UVA sample. The results were similar in the low-risk and high-risk subgroups as well ( Figure 3B ).
The overall predicted event rate using model C, which used clinical data along with the number of diseased vessels on coronary angiography, closely agreed with the overall observed rate in the MGH cohort from which it was derived ( Figure 4A ). In this sample, a high-risk subgroup of 60 patients with a history of infarction and multivessel CAD and a low-risk subgroup of 70 patients with no prior infarction and either one-vessel CAD or no CAD were identified. As in the entire cohort, the observed and predicted survival curves were also in close agreement for these two subgroups ( Figure 4A ). When the validity of this model was tested in the UVA cohort, it also provided reasonable prediction of the survival rates of cardiac events in the entire patient cohort as well as in the low-risk and high-risk subgroups (Figure 4B) . A similar result was obtained when model D (developed at UVA) was tested in the MGH cohort. When this model (which was derived using clinical and 201T1 imaging data) was tested for goodness-of-fit in the UVA sample, it accurately predicted the observed survival in the entire group ( Figure 5A ). This model also remained reliable in the 60 low-risk patients who were not on fl-blockers and who had no evidence of redistribution, as well as in the 48 high-risk patients who were on fl-blockers and who had one or more segments showing redistribution ( Figure 5A ). When the validity of this model was tested in the MGH cohort, it provided reasonable predictions of survival rates of the entire 204 patients and those of the 49 low-risk patients ( Figure 5B ). The predicted survival was also similar to the observed rates in the 39 high-risk patients for the first 4 years of follow-up. After this period, there was a divergence between observed and predicted rates because no events were observed between 4 and 8 years ( Figure SB) . The number of patients followed after 4 years, however, was small: 18 at 5 years, 11 at 6 years, six at 7 years, and three at 8 years, respectively. Model E was generated using clinical and coronary angiographic data from the UVA cohort. When tested for goodness-of-fit in the same sample, it closely predicted the survival rates of the entire patient cohort as well as for the 63 low-risk patients (who were not on 13-blockers and had one-vessel CAD or no CAD) and the 86 high-risk patients (who were on 13-blockers and had multivessel CAD) ( Figure 6A ). This model also closely predicted event rates when it was tested in the entire MGH cohort ( Figure 6B) . The When`01T1 imaging data were analyzed, the lung/ heart '01T1 ratio and number of defects with redistribution were found to be significant predictors of events. Addition of`01T1 variables added significantly to the prognostic value of clinical and exercise stress test data, particularly if the lung/heart`01T1 ratio was known. When the lung/heart`01T1 ratio was included in the analysis, the number of diseased vessels on coronary angiography did not add to the prognostic information available from clinical, exercise stress test, and 201T1 data. If, however, this variable was not included in the analysis and only the number of segments with redistribution were counted, the number of diseased vessels on coronary angiography added significantly to the clinical, exercise stress test, and '01T1 data. The overall prognostic importance of clinical, exercise stress test, and angiographic data was inferior to clinical, exercise stress test, and`01TI data when the lung/heart 201T1 ratio was analyzed.
Development of Models to Predict Prognosis
Investigators have used logistic regression analysis for determining prognosis.' This approach provides the capability of estimating absolute risk in a particular patient but ignores variability in the follow-up interval of patients from whom the model is derived unless they are properly adapted for the analysis of survival data. Because it is more likely for a patient with the same risk factors to develop an event if he or she is followed for a longer period compared with another followed for a shorter period, models developed by using ordinary logistic regression are not valid unless the follow-up period is the same in all patients. To overcome this limitation, Cox proportional hazards analysis34 or an adapted logistic model36,37 is used in which the follow-up interval is factored into the analysis.
In the present study, we used a time-sensitive adaption of the logistic regression analysis to develop models from which the probability of an event for an individual patient could be reported and calculated by the clinician. These models yield results that are very similar to the Cox models. 37 The variables included in our models were selected from two or more of the four categories that were analyzed in this study. The models were developed to answer clinically relevant questions in different scenarios. They were examined in the cohort from which they were derived, whereas their validity was tested in an unrelated sample.
Our results indicate that lung/heart ratio provides the greatest incremental information to clinical and exercise stress test data. When this variable is known, knowledge of coronary anatomy does not provide any additional prognostic information. Furthermore, the combined prognostic information from clinical, exercise stress test, and`01T1 lung/heart ratio is greater l H~ than that from the combination of clinical, exercise stress test, and angiographic data. This finding should not be surprising. Increased lung/heart`01T1 ratio implies exercise-induced pulmonary edema and has been correlated with the number of diseased vessels on angiography, resting left ventricular function, low double product during exercise, and presence of clinical heart failure.29 Using a model based on clinical information and lung/heart`01T1 ratio in the patient cohort from which it was derived, we found that not only was the overall event rate correctly predicted (as would be expected, because the model was derived from this population), but also that low-risk and high-risk subgroups were correctly identified. Because quantitation of the lung/heart`01T1 ratio was not being performed routinely at the time these data were collected, we could not test the validity of the model incorporating this variable in another unrelated sample.
We were able to test models based on clinical information and number of defects with redistribution in unrelated patient samples. The presence or absence of redistribution is routinely assessed on 201T1 imaging and implies the presence of significant stenosis proximal to viable myocardium. 28 The model developed at UVA performed well in the sample at MGH, but the model developed at MGH did not perform as well in the UVA cohort. Nevertheless, although the latter model was not accurate in determining absolute risk in an unrelated patient cohort, it was very effective in stratifying patients in this sample into low-risk and high-risk subgroups. That is, the relation between redistribution and a cardiac event is duplicated in an unrelated sample, implying that whereas absolute risk in different samples might be different, associations may be generalized.
In many situations, patients undergo cardiac catheterization after exercise testing without also undergoing 201T1 imaging. Models were, therefore, developed to include clinical (and exercise stress test) data along with the number of diseased vessels to predict adverse cardiac outcome. In general, these models also performed well in identifying overall prognosis in an unrelated sample. It is important to note, however, that clinical (and exercise stress test) data added significant information to the angiographic data and substantially enhanced the power of coronary anatomy alone in predicting events. Furthermore, although both models were good at predicting overall survival, the one developed at UVA was not as good in stratifying between low-risk and high-risk subgroups at MGH. Because of the small sample sizes, differences between predicted and observed survival in these subgroups were not statistically significant; however, these differences may be clinically meaningful. Study Limitations The models were generated from referral populations in tertiary care centers, and although they often seemed useful for separating low-risk and high-risk subgroups, their use in community hospital practice needs to be tested. Selection bias is evident from the fact that the patients studied both at MGH and UVA constituted approximately 10-12% of patients undergoing exercise '01TI imaging at these institutions at the time these data were collected. Selection bias in terms of gender is also shown in the relatively younger age groups for both patient cohorts in which, as evident from the data, CAD is more prevalent in men. The importance of variables such as lung/heart ratio and redistribution on 201TI imaging has, however, also been documented in unselected patients not undergoing concomitant coronary angiography. 2, 5, [7] [8] [9] Because patients undergoing early bypass surgery (within 3 months of testing) were excluded from analysis, these results pertain to medically treated patients. At the time these data were collected (1978) (1979) (1980) (1981) , the decision to offer bypass surgery was based largely on results of the exercise stress test and coronary angiography. Had bypass surgery been included as an end point, the prognostic value of both the exercise stress test and cardiac catheterization would have been greater. When these data were collected, it was not common practice to send patients to surgery based on the results of exercise 201T1 imaging. Consequently, the true independent and additive prognostic value of this test is probably well represented in this study. That a significant minority of patients from both cohorts had 201T1 imaging after coronary angiography was probably because of the need to determine the physiological significance of particular coronary stenoses in these patients rather than to assess their prognosis.
Because cineangiography was not performed in all patients, we did not include left ventricular ejection fraction in the analysis. It is possible that had this variable been included, the prognostic power of cardiac catheterization would have been greater.14 The measurement of left ventricular ejection fraction, however, can also be obtained using noninvasive techniques such as blood pool imaging and twodimensional echocardiography (which can also be acquired during exercise). Consequently, it can be argued that had either of these tests been obtained, the prognostic value of noninvasive testing also could have been higher. 43'44 A useful means for validating the models is in observing how well they perform in various subsets of patients. In our study, no significant differences between the observed and modeled survival curves in the low-risk and high-risk groups were noted, and none of the probability values that were derived from such comparisons came close to being noteworthy. Unfortunately, when evaluating model performance in the low-risk and high-risk groups, sample sizes became excessively small and the statistical power to detect failure in the models became limited. In this regard, it is especially interesting to us to try to identify factors that might explain the underprediction and overprediction of a model in the low-risk and high-risk subgroups and the factors that we failed to observe that can differentiate between the survival experience in rural (UVA) and urban (MGH) communities.
Clinical Implications
There are several practical issues that relate to the results of these studies. First, it would seem that quantitative exercise 20`T1 imaging with measurement of the lung/heart 20`T1 ratio could be advocated as an optimal noninvasive means for determining prognosis in ambulatory patients with suspected CAD. Second, based on our results, it could be argued that the exercise stress test alone (without cardiac imaging) may not provide useful prognostic information in excess of that already provided by the clinical data. Third, it should be emphasized that these results pertain to two institutions with considerable experience with quantitative planar`'Tl imaging. Whether identical information can be obtained from visual assessment of planar or reconstructed tomographic images needs to be seen. Although there are ample data suggesting that important prognostic information can be derived from planar images,1-9 the longterm prognostic value of tomographic imaging has not been yet documented.
Although not tested in this study, it could be argued that similar prognostic information could also be obtained in laboratories with expertise in other forms of cardiac imaging such as exercise radionuclide angiography43 or exercise echocardiography. 44 Even though a single test may provide powerful prognostic information, it may not reveal the entire prognostic profile of a given patient. For instance, although the levels of risk in patients with threevessel and one-vessel CAD can be discriminated using coronary angiography, patients with two-vessel disease and no other risk factors such as prior infarction may need to undergo additional testing PI denotes the probability of an event during the first year of follow-up, conditioned on survival at the beginning of that interval. There were no significant changes in the intercept term with time implying that, for a given set of risk factors, the probability of an event is the same for each year of follow-up, provided that the patient has survived to the beginning of that interval. The estimated probability of survival through the first year of follow-up, S(I), is given by S(I) = w[1-Pi](37)ic I To test models B and C in UVA patients, the intercepts were used from the UVA population and the coefficients were used from the MGH cohort. For models B and C, therefore, the intercepts were -4.02 and -4.65, respectively, instead of -3.81 and -4.30, respectively. Similarly, to test models D and E in the MGH patients, the intercepts were used from the MGH population and the coefficients were used from the UVA cohort. These intercepts were, therefore, -2.55 and -3.23 for models D and E, respectively, instead of -2.57 and -3.57.
Although our use of intercepts from a sample being predicted can improve the performance of the prediction by an unrelated group, we were interested in determining whether failures in prediction could still be observed. If so, the failure of one model to make predictions in an unrelated sample could be better attributed to factors other than underlying forces of morbidity and mortality. There were, in fact, instances when models failed, and in such cases, we believe and expect that unobserved factors exist that might explain differences in absolute survival between unrelated cohorts. The comparisons we provide become especially useful when predictions are made in low-risk and high-risk groups. Of course, the fact that there were no significant failures in prediction could always be attributed to limited sample sizes, although from a clinical point of view, discrimination by an unrelated sample into low-risk and high-risk subgroups generally seems to perform well.
